U.S. Cell Line Development Market Size & Outlook

The cell line development market in the United States is expected to reach a projected revenue of US$ 3,629.0 million by 2030. A compound annual growth rate of 9.6% is expected of the United States cell line development market from 2024 to 2030.
Revenue, 2023 (US$M)
$1,908.2
Forecast, 2030 (US$M)
$3,629.0
CAGR, 2024 - 2030
9.6%
Report Coverage
U.S.

U.S. cell line development market, 2018-2030 (US$M)

U.S.

U.S. cell line development market highlights

  • The U.S. cell line development market generated a revenue of USD 1,908.2 million in 2023 and is expected to reach USD 3,629.0 million by 2030.
  • The U.S. market is expected to grow at a CAGR of 9.6% from 2024 to 2030.
  • In terms of segment, reagents & media was the largest revenue generating product & service in 2023.
  • Services is the most lucrative product & service segment registering the fastest growth during the forecast period.


Cell line development market data book summary

Market revenue in 2023USD 1,908.2 million
Market revenue in 2030USD 3,629.0 million
Growth rate9.6% (CAGR from 2023 to 2030)
Largest segmentReagents & media
Fastest growing segmentServices
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationReagents & Media, Equipment, Accessories and consumables, Services
Key market players worldwideThermo Fisher Scientific Inc, Danaher Corp, Sartorius AG, Merck KGaA, Corning Inc, Lonza Group Ltd, Creative-Biolabs, Wuxi AppTec Co Ltd, Advanced Instruments


Other key industry trends

  • In terms of revenue, U.S. accounted for 36.4% of the global cell line development market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. cell line development market is projected to lead the regional market in terms of revenue in 2030.
  • Canada is the fastest growing regional market in North America and is projected to reach USD 327.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Cell Line Development Market Scope

Cell line development market segmentation & scope
Reagents & Media
Bioreactors
Automated systems
Centrifuges
Storage equipment
Others
Accessories and consumables
Services
Mammalian Cell Line
Insects
Amphibians
Recombinant Cell Lines
Hybridomas
Continuous Cell Lines
Primary Cell Lines
Bioproduction
Drug discovery
Toxicity testing
Tissue engineering & regenerative medicine
Others

Cell Line Development Market Companies

Name Profile # Employees HQ Website

U.S. cell line development market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell line development market will help companies and investors design strategic landscapes.


Reagents & media was the largest segment with a revenue share of 43.4% in 2023. Horizon Databook has segmented the U.S. cell line development market based on reagents & media, equipment, accessories and consumables, services covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to U.S. cell line development market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of U.S. cell line development market databook

  • Our clientele includes a mix of cell line development market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the U.S. cell line development market , including forecasts for subscribers. This country databook contains high-level insights into U.S. cell line development market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

U.S. cell line development market size, by product & service, 2018-2030 (US$M)

U.S. Cell Line Development Market Outlook Share, 2023 & 2030 (US$M)

U.S. cell line development market size, by product & service, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more